Compound 4
N-(2-Methyl-3-(4-methyl-6-((4-(morpholine-4-carbonyl)phenyl)amino)-5-oxo-4,5-dihydropyrazin-2-yl)phenyl)acetamide
From: Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis
View in PubChem | MDL Molfile | ChemDraw
InChIKey BIHCTMIAUVYGCP-UHFFFAOYSA-N